METHODS: The current study was conducted in a total of 612 patients (n =6 12) receiving an implant-based augmentation mammaplasty at other hospitals between August 31, 2017 and August 31, 2020. Of these, 136 patients (n = 136; 272 breasts) receiving reoperation were included in the current study. We compared between the patients\' subjective awareness of a breast implant and its HRUS findings and an agreement between HRUS findings of a breast implant and its findings at reoperation.
RESULTS: The proportion of the patients receiving a silicone gel-filled breast implant was increased from 65.44% (89/136) to 81.61% (111/136) on HRUS. Moreover, HRUS was effective in identifying a manufacturer of the device.
CONCLUSIONS: In conclusion, our results indicate that HRUS is feasible in characterizing a breast implant in patients receiving an implant-based augmentation mammaplasty. But further prospective, large-scale studies are warranted to corroborate our results.
METHODS: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors. www.springer.com/00266 .
方法:本研究是在2017年8月31日至2020年8月31日期间在其他医院接受基于植入物的隆乳术的612例患者(n=6.12)中进行的。其中,本研究包括接受再次手术的136例患者(n=136;272例乳房)。我们比较了患者对乳房植入物的主观认识及其HRUS发现,以及乳房植入物的HRUS发现与再次手术时的发现之间的一致性。
结果:在HRUS上,接受硅凝胶填充乳房植入物的患者比例从65.44%(89/136)增加到81.61%(111/136)。此外,HRUS有效地确定了设备的制造商。
结论:结论:我们的结果表明,HRUS在表征接受基于植入物的隆乳术患者的乳房植入物方面是可行的.但进一步的前景,有必要进行大规模的研究来证实我们的结果.
方法:本期刊要求作者为每篇文章分配一定程度的证据。对于这些循证医学评级的完整描述,请参阅目录或在线作者说明。www.springer.com/00266.